Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Current Leases (2022 - 2025)

Historic Current Leases for LifeStance Health (LFST) over the last 4 years, with Q3 2025 value amounting to $47.4 million.

  • LifeStance Health's Current Leases fell 323.13% to $47.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.4 million, marking a year-over-year decrease of 323.13%. This contributed to the annual value of $49.4 million for FY2024, which is 639.91% up from last year.
  • According to the latest figures from Q3 2025, LifeStance Health's Current Leases is $47.4 million, which was down 323.13% from $47.1 million recorded in Q2 2025.
  • In the past 5 years, LifeStance Health's Current Leases registered a high of $49.7 million during Q1 2024, and its lowest value of $38.8 million during Q4 2022.
  • Its 4-year average for Current Leases is $46.1 million, with a median of $47.2 million in 2025.
  • Per our database at Business Quant, LifeStance Health's Current Leases soared by 1970.69% in 2023 and then tumbled by 488.25% in 2025.
  • Quarter analysis of 4 years shows LifeStance Health's Current Leases stood at $38.8 million in 2022, then rose by 19.71% to $46.5 million in 2023, then rose by 6.4% to $49.4 million in 2024, then dropped by 4.19% to $47.4 million in 2025.
  • Its Current Leases stands at $47.4 million for Q3 2025, versus $47.1 million for Q2 2025 and $47.3 million for Q1 2025.